Share Name Share Symbol Market Type Share ISIN Share Description
Eden LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.125p -1.22% 10.125p 10.00p 10.25p 10.25p 10.125p 10.25p 54,000 11:39:39
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.4 -1.9 -1.0 - 20.97

Eden Share Discussion Threads

Showing 3251 to 3273 of 3275 messages
Chat Pages: 131  130  129  128  127  126  125  124  123  122  121  120  Older
DateSubjectAuthorDiscuss
19/10/2017
12:14
A good many years ago I held shares in Axis Shield which was taken out by an American company at what many thought was a much undervalued price. Sooner or later one of the 'big boys' might have a pop at Eden whose current market cap, a paltry £21.22m. is pocket money for them. Would anybody care to suggest what a fair take out price might be and maybe which if any of the 'big boys' might make it? I've absolutely no idea how to estimate such a fair price but I would be happy with 50p per share. Just something to do while we wait and wait and .........
littlealbatross2
19/10/2017
10:27
That Times article says that the former minister for universities and science, Lord Willetts, who is also on the board of the Bioindustry Association trade body, says that promising UK biotech companies often list on Nasdaq, not AIM, because British investors don’t understand their tech. Potential investors in the UK ask rather too elementary questions about science, but in the USA, however, investors tend to have a doctorate in the exact subject. [I don’t understand that, perhaps he means that II’s in the USA have such people on call for advice; otherwise it doesn’t quite make sense if taken literally, sounding like wild exaggeration - but certainly ignorance of even basic science is widespread in UK]. He added that people giving up science at school after GCSE’s has led to GB City investors’ ignorance. He added that companies are being "spun out" of universities and listed on AIM etc prematurely, adding they should be matured in university laboratories for longer, and given more financial backing by uni’s.
paulpaolo
18/10/2017
14:50
The International Panel of Experts on Sustainable Food Systems (IPES-Food) Expert panel identifies unacceptable toll of food and farming systems on human health hTTp://www.theecologist.org/News/news_analysis/2989371/expert_panel_identifies_unacceptable_toll_of_food_and_farming_systems_on_human_health.html ,,,,,,,,,.......................................................................... hTTps://www.theguardian.com/environment/2017/oct/18/warning-of-ecological-armageddon-after-dramatic-plunge-in-insect-numbers?CMP=Share_AndroidApp_Facebook .............................................................................. hTTp://www.independent.ie/business/farming/forestry-enviro/meps-propose-glyphosate-phaseout-with-full-ban-by-end-2020-36242467.html
supersonico
17/10/2017
20:03
Really Super !You have single handedly sent all the Eden investors to sleep on here over the last 6 months !Anyway what is there to talk about ? 3rd quarter financial update maybe ?
quazie12
17/10/2017
19:33
You don't half talk dull nonsense Q12. Try and Up your game.. make it a little interesting for those who read this BB. Ta
supersonico
17/10/2017
19:17
Nothing changes SuperJust keep up your solo ramping and deflect from discussing real issues.Your constant posting has Not made a jot of difference to the sp, company take over prospects or induce the bod to add to their minuscule holdings. Any sales updates from the company recently ?
quazie12
17/10/2017
15:43
Intriguing tweet from Eden yesterday..with some interesting connections ?? hTTp://www.cityam.com/273916/playing-long-game-interview-chapel-down-ceo-frazer-thompson?utm_source=dlvr.it&utm_medium=dvTwitter I can see the head line.. 'Paul Scott toasts plonka Fraudy with Eden Tech treated Chapel Down wine at Uk investor event' Do I detect a caption contest opportunity..
supersonico
17/10/2017
13:35
NorthwickI cannot recall ANY buys fromdirectors in the last 18 months.Other than the FD's holding the rest of the Board are either negligible or zero. You most likely own more than the lot if them COMBINED (AA excepted) ! PMSL
quazie12
17/10/2017
12:46
Certainly would be welcome ..
supersonico
17/10/2017
10:08
Good morning allWhy aren't the directors dipping their fingers in their pockets to buy more shares in Eden. Do all of them still think the Co is overvalued, or are they prohibited by City Rules ( in close period). also, when will the new Chairman buy his shares- he is after all an officer of the company!What's stopping them?
northwick
16/10/2017
20:58
Moronic Trump... Nominates Human Extinction accelerator Michael Dourson as Chemical safety head. hTTps://www.theguardian.com/us-news/2017/sep/20/trump-epa-michael-dourson-chemical-safety hTTps://www.facebook.com/NowThisPolitics/videos/1738032556228227/?hc_ref=ARS36nuXva7TjQ2oVGLzoOdYe3Dk8a_fsc82rtp53RtJ1AhvD2msAKZ-l8jpJwyaqnc
supersonico
16/10/2017
14:23
Supersonico, Someone presumably, is mopping those 100,000 shares up. Let's hope you're right and an RNS to the same is forthcoming.
investingisatrickygame
16/10/2017
14:08
Investing; Wish I knew. The deals Eden are making and the talent it has attracted both recent and historically and are all positive IMO. Lykele van der Broek could most likely could have made any number of choices including putting his feet up. He chose Eden, that speaks volumes to me at least. I'm convinced we've had a long term buyer as well for a good time and would not be surprised if we see some sort of holding RNS sooner or later.
supersonico
16/10/2017
12:35
Investingisatrickygame, Why " "successful" "? From a making profits perspective it's definitely NOT successful! JakNife
jaknife
16/10/2017
12:19
So Eden does it for £12 million. Back to your original question. Why no bid interest now with 3AEY proven and "successful"
investingisatrickygame
16/10/2017
07:41
hTTp://www.croplife.com/management/crop-protection-market-pressure-leading-supplier-consolidation/ In many cases, this means growers are looking to crop protection/seed companies for new innovations/products to help manage increasingly aggressive/resistant pests/weeds, he said. “New product development costs, for both seeds and chemicals, are in the range of $300 million to $500 million in development and registration globally,” said DeLisi. “Only the latest companies have the resources and leverage to both finance and then recapture this level of investment in an attempt to ‘stay ahead of the weeds and bugs.’ Mergers were chosen as the path to increased revenues to allow for more research and development expenditures while protecting shareholder value.”
supersonico
15/10/2017
22:05
Oct. 13, 2017 European Commission calls for more sustainable use of pesticides in EU hTTp://news.agropages.com/News/NewsDetail---23973.htm hTTps://ec.europa.eu/food/plant/pesticides/sustainable_use_pesticides_en
supersonico
15/10/2017
16:43
It doesn't, but David Willets is easily contactable and so I will.
investingisatrickygame
15/10/2017
16:14
Investing, Indeed very relevant to our discussion. Interesting that it sounds like a sector issue Does the article have any other interesting snippets..I'm not a Times Subscriber so the header is all I can View??
supersonico
15/10/2017
15:40
That's the one supersonico. Quite apt I thought given our recent to and fro on here.
investingisatrickygame
15/10/2017
14:47
IInvesting, I'm not going near a newsagent today so unable to have a look..other than this.. hTTps://www.thetimes.co.uk/article/lord-david-willetts-warns-over-biotech-ignorance-of-uk-investors-zn277n8c7 Can you summarise any other interesting details of article..thanks
supersonico
15/10/2017
13:34
Supersonic, Read the Times today, business section, page 3 "UK investor biotech ignorance"
investingisatrickygame
14/10/2017
15:07
supersonico, Sipcam appear to be doing a very positive rollout, on that we are agreed. But the results of the same will only be made to shareholders each 6 months through the interims and annual results. What about the other 11 months of the year? Is every shareholder supposed to sit on dead money? If Shore Capital cannot execute then Powerscourt, an LSE-AIM non-mandatory/regulatory requirement, need to ensure they do execute, for shareholders, in return for their monthly fees from Eden. If not, why employ them? I think we are broadly on the same path, but probably differ in specific regards to investor relations and what does or does not need doing for/by Eden.
investingisatrickygame
Chat Pages: 131  130  129  128  127  126  125  124  123  122  121  120  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20171019 12:44:06